Incorporated in 1995, Ind-Swift Laboratories Ltd is engaged in the manufacturing of Active Pharmaceutical Ingredients(APIs), and Advanced Intermediates, and providing Contract Research and Manufacturing Services (CRAMS).
Financial Results:
- Ind-Swift Laboratories Ltd reported Revenues for Q1FY24 of ₹310.00 Crores up from ₹280.00 Crore year on year, a rise of 10.71%.
- Total Expenses for Q1FY24 of ₹284.00 Crores up from ₹267.00 Crores year on year, a rise of 6.37%.
- Consolidated Net Profit of ₹17.00 Crores down 15.0% from ₹20.00 Crores in the same quarter of the previous year.
- The Earnings per Share is ₹2.92, down 13.10% from ₹3.36 in the same quarter of the previous year.